2024-02-17 05:05:44 ET
In 2023, revenue decreased by 2% due to lower sales in sequencing consumables and instruments. Operating expenses showed significant changes, impacting net income margin. Management focuses on strategic collaborations and cash management. Key performance indicators remained stable, reflecting financial transparency. Risks include geopolitical instability and cybersecurity threats. The board prioritizes diversity and sustainability. Forward guidance emphasizes innovation and capitalizing on DNA s ... Full story available on KlickAnalytics.com